Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Apr 7, 2014

Accelerate Diagnostics Commences Rights Offering
TUCSON, Ariz., April 7, 2014 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that it has commenced a $45,000,000 rights offering to fund its product commercialization ef...Read more

Jan 31, 2014

Accelerate Diagnostics Launches Investor Portal to Website
TUCSON, Ariz., Jan. 31, 2014 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has launched a new investor relations portal on its website and will be using this p...Read more

Nov 6, 2013

Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors
TUCSON, Ariz., Nov. 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Mark C. Miller has been appointed to its Board of Directors.Mr. Miller currently ser...Read more

Aug 13, 2013

Accelerate Diagnostics Announces Final Results of Rights Offering
TUCSON, Ariz., Aug. 13, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider investors, the Company raised $20,000,000, including proceeds from a standby commitment made by Abeja Ventures, LLC. Stockho...Read more

Jul 12, 2013

Accelerate Diagnostics Announces Final Terms of Rights Offering
TUCSON, Ariz., July 12, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today the final terms of its previously announced $20,000,000 rights offering. The Company anticipates th...Read more

Jul 1, 2013

Accelerate Diagnostics Appoints Chief Commercial Officer
TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today.Most recently Pete was Sr. Vice President and General Manager of Ventana Medical Systems' North American Commercial Operations. Previously, Pete...Read more

Jul 1, 2013

Accelerate Diagnostics Joins the Russell 2000® Index
TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has joined the Russell 2000®, Russell 3000®, and Russell Global Indexes following Russell's r...Read more

Jun 4, 2013

Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (t...Read more

Mar 6, 2013

Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors
TUCSON, Ariz., March 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Frank J.M. ten Brink has been appointed to its board of directors.Mr. ten Brink has more tha...Read more

Dec 12, 2012

Accelerate Diagnostics goes to NASDAQ
DENVER, Dec. 12, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing on the NASDAQ Capital Market. The Company expects to commence trading on NASDAQ under the ticker symbol "AXDX" on Wednesday, December 26, 2012. Until such date, th...Read more
FirstPrevious
1
...
4
5
6
7
8
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 24.55
-0.60
(2.39%)
4:00 PM ET on Feb 20, 2018
Day High: 25.25
Day Low:  24.50
Volume:    164,067
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates